

AI denials are bad news for providers.
A full 61% of physicians fear that unregulated use of artificial intelligence by payers is creating an increase in prior authorization denials [1]. This growing issue directly impacts medical decision making, worsen the patient experience and in turn, the patient financial experience. But it isn’t just the American Medical Association calling attention to this problem.
Major Medicare Advantage plans – including UnitedHealthcare, Humana, and CVS – are implementing AI solutions with a focus on post-acute care including nursing homes and rehab facilities. These automated systems are fast-tracking denial decisions, and the result has been a notable spike in denial rates. Between 2020 and 2022, UnitedHealthcare doubled its post-acute denial rates using “machine-assisted” reviews [2]. As these changes accelerate, revenue cycle leaders must respond just as swiftly. One of the most common responses is providers employing their own AI solutions to appeal and follow-up on denials and underpayments. This is a good start, but it doesn’t get at the root cause of the problem.
What we’re seeing with payer-side AI tools is a more precise application of contract terms – including provisions like clean claim technicalities, unilateral amendment clauses, silent PPO discounting, and all products clauses. This means two things:
For many healthcare providers, overhauling payer contracts, denial metrics, and technology workflows all at once can feel overwhelming. That’s why outsourcing medical billing and partnering with RCM specialists with strong AI technology can be a practical first step. Not only can it relieve internal teams, but it ensures that payer contract management and denial tracking are handled with expert oversight.
In today’s increasingly complex payer landscape, the smartest provider organizations will embrace a multi-pronged RCM strategy – one that includes better contracting, better data, and better technology. After all, that’s the approach payers are taking.
[1] J. Lubell, "How AI is leading to more prior authorization denials," American Medical Association, 10 March 2025. Available: https://www.ama-assn.org/practice-management/prior-authorization/how-ai-leading-more-prior-authorization-denials.
[2] M. L. Shaw, "Insurers’ AI Denials of Postacute Care Face Senate Scrutiny," AJMC, 28 October 2024. Available: https://www.ajmc.com/view/insurers-ai-denials-of-postacute-care-face-senate-scrutiny.
Hemant Apte is the Founder and CEO of 3Gen Consulting, a leading healthcare revenue cycle management and technology company serving providers, ACOs, and health plans across the U.S. Since founding 3Gen in 2006, Hemant has guided the company’s evolution from a boutique consulting firm into a data-driven organization at the forefront of AI-powered RCM innovation. With decades of experience in U.S. healthcare operations, Hemant continues to provide thought leadership to clients navigating financial, compliance, and technology challenges in an increasingly value-based care environment.
Learn how smarter payer contracting helps you stay ahead of AI-assisted denials.


The FAQ section simplifies key information about 3Gen Consulting’s services, helping partners navigate our offerings, methodologies, and value.
AI tools used by payers are automating prior authorization and post-acute denials, leading to faster and higher denial rates in 2025.
Major MA payers like UHC and Humana are using machine-assisted reviews to apply contract terms more aggressively, especially for post-acute care.